4/A//SEC Filing
Guerrero Ramiro 4/A
Accession 0001127602-25-008317
CIK 0001878313other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 4:37 PM ET
Size
7.4 KB
Accession
0001127602-25-008317
Insider Transaction Report
Form 4/AAmended
Guerrero Ramiro
Director
Transactions
- Purchase
Warrants
2025-02-24$1.87/sh+73,333$137,133→ 73,333 totalExercise: $1.87From: 2026-02-25Exp: 2031-02-25→ Common Stock (73,333 underlying) - Purchase
Common Stock
2025-02-24$1.50/sh+73,333$110,000→ 534,885.04 total
Footnotes (3)
- [F1]The common stock was purchased pursuant to a Securities Purchase Agreement and were issued under the Issuer's 2021 Equity Incentive Plna on February 24, 2025.
- [F2]This Form 4/A is being filed to correct the "Date Exercisable" and "Expiration Date" in Section 6 of Table II reported in the original Form 4 filed on February 25, 2025 as well as to correct the date of the Securities Purchase Agreement orginally referenced in the footnote 1 and 2 to "February 24, 2025".
- [F3]These warrants were purchased pursuant to a Securities Purchase Agreement and were deemed options issued under the Issuer's 2021 Equity Incentive Plan on February 24, 2025. The options are exercisable beginning on the one-year anniversary of the issuance date and expire 6-years after the initial issuance date.
Documents
Issuer
MAIA Biotechnology, Inc.
CIK 0001878313
Entity typeother
Related Parties
1- filerCIK 0001913253
Filing Metadata
- Form type
- 4/A
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 4:37 PM ET
- Size
- 7.4 KB